Comments on: Allscripts to Acquire Eclipsys for $1.3 Billion, Misys to Sell Its Stake

By: formermisys

formermisys — Fri, 11 Jun 2010 03:43:54 +0000

GT Quote – “…the fastest transformation in healthcare..”

Guidance – growth at 8-10% – something seems amiss. I would think the company would grow at 15-20% if it was truly winning market share. The reality is Management is all about sell, sell, sell while the customer base is leaving rapidly. It will be interesting to watch the next few earnings reports.

By: Good to Great

Good to Great — Thu, 10 Jun 2010 18:31:51 +0000

Great to see quality leadership and products come together in Healthcare. The Allscripts Merger with Eclipsys brings together two very well run organizations with exceptional product offerings. Both organizations have continued to develop, deliver and support exceptional solutions. As with any software solution there are some challenges, put any other vendor under the microscope and you will see those problems too. This merger seems to be looking towards the future and the good that these two companies can do together. There is very limited to no overlapping solutions. This is nothing like the HBOC/McKesson days when you bought your competitor for market share, this is a strong merger that brings together the best solutions. Integrate or Interface, no kidding it will be interfacing at first, so what, the data still flows, the clinical staff get a good workflow and that is a win for the patient. A temporary down turn in the stock price, take a look at the Allscripts track record and continued growth and by the way significant hiring they have been doing during a down economy. As someone who is more on the side lines of healthcare today, having worked through the HBOC days, time with Eclipsys, this move makes great sense to move healthcare in a better direction.

By: gladtobelongone

gladtobelongone — Thu, 10 Jun 2010 00:21:32 +0000

Not to happy is right on the nose with the new company name! Both companies have been “cobbled” together like HBOC did in the 1980′s and they couldn’t deliver squat then. Neither one of these organizations are delivering too well except to their talking head customers and Eclipsys case only to those that are outsourced so that they get the “A” team. There is going to be a ton of sunsetting on the product side and huge defections by those who feed the fire on the revenue side. Hopefully customers will be smarter and not buy into this marketing hype/crap. Not to be a told you so, but I believe that I posted back in Sept/Oct 2009 that Phil Pead’s vision was nill and he was in it strictly for the mighty buck just like every other position he has held. I have trouble believing that customers are so naive to believe anything that comes out of that “Bloke’s” trap. The only saving grace for HBOC was McKesson and that still hasn’t turned out too good and the only hope for both Allscripts and Eclipsys customer will be that Microsoft will come in and “save” the day.

By: PezMan

PezMan — Wed, 09 Jun 2010 22:25:01 +0000

Suzy – Devices? You have to be kidding me… Please stop posting until you have something meaningful to say.

RE: Allscripts/Eclipsys – This will be an interesting development with the purchase/merger. All great points brought up about their competing strategies with HIE and other crossovers in the Ambulatory sector (not sure if there really was a strong product there for Eclipsys). I know it’s all speculation now, but where do you think the two companies sit with employee fallout?

By: John@Chilmark

John@Chilmark — Wed, 09 Jun 2010 22:14:46 +0000

Talked to these two companies’ HIE partners and put together a post on the implications of this merger to their respective HIE initiatives which you’ll find at:
http://chilmarkresearch.com/2010/06/09/allscriptseclipsys-who-looses/

Welcome one and all’s comments.